Fresh WHO guidelines for malaria
The World Health Organization (WHO) has recommended a combination therapy to ensure that Plasmodium falciparum, the malaria parasite, does not develop resistance against the drug artemisinin. This is the only drug effective against falciparum malaria at present. WHO's malaria department has also asked pharmaceutical companies to stop marketing single-drug tablets.
The guidelines have been welcomed by the public private partnership, Drugs for Neglected Diseases initiative, that recently came out with two such combinations. But the international NGO, Medicins Sans Frontieres, suggests artemisinin monotherapies may still be needed by patients who cannot tolerate the other components of combination drugs. Indian manufacturers like Cipla say they would continue to produce the single drug.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
.png)
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.